Skip to main content
Investor Relations Contact Us Careers
Nasdaq: FEMY
News Item

Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF

February 28, 2024

Femasys highlighted how FDA clearance of FemaSeed brings timely access to a first-line infertility treatment option as an alternative to IVF.

View source →
← Back to Media